H Tilly, F. Morschhauser, G. Salles, R-O Casasnovas, P Feugier, et al.. Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2013, 27 (1), pp.252 - 255.
⟨10.1038/leu.2012.172⟩.
⟨hal-01707019⟩